Phathom Pharmaceuticals PHAT - 옵션 체인 | ADVFN

다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Phathom Pharmaceuticals Inc (PHAT)
Phathom Pharmaceuticals Inc (PHAT) 옵션

Phathom Pharmaceuticals Inc (PHAT)

5.67

0.13

(2.35%)

마감 24 2월 6:00AM

5.77

0.10

(1.76%)

시간외 거래: 8:56AM

PHAT 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
2.50	2.45	4.90	3.32	3.675	0.00	0.00 %	10	0	22/02/2025
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.15	0.30	0.25	0.225	0.05	25.00 %	480	1,724	22/02/2025
10.00	0.25	4.50	0.25	2.375	0.00	0.00 %	0	71	-

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	2.00	4.50	0.00	3.25	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
MLGOMicroAlgo Inc	US$ 6.3767 (454.50%)	531.54M
BOXLBoxlight Corporation	US$ 3.1099 (51.70%)	1.84M
GDEVGDEV Inc	US$ 20.90 (46.56%)	264.44k
IVVDInvivyd Inc	US$ 1.7501 (44.64%)	37.75M
UPCUniverse Pharmaceuticals Inc	US$ 0.2003 (40.56%)	420.21M
DOYUDouYu International Holdings Ltd	US$ 7.19 (-55.31%)	1.28M
MNDRMobile health Network Solutions	US$ 0.5048 (-46.29%)	18.61M
BLUEbluebird bio Inc	US$ 4.09 (-41.90%)	5.44M
FLDFold Holdings Inc	US$ 6.95 (-37.39%)	488.54k
GCLGCL Global Holdings Ltd	US$ 3.83 (-31.48%)	635.26k
MLGOMicroAlgo Inc	US$ 6.3767 (454.50%)	531.54M
UPCUniverse Pharmaceuticals Inc	US$ 0.2003 (40.56%)	420.21M
ADTXAditxt Inc	US$ 0.0922 (-22.39%)	278.25M
NVDANVIDIA Corporation	US$ 134.43 (-4.05%)	228.14M
HOLOMicroCloud Hologram Inc	US$ 1.565 (31.51%)	190.81M

rolvram

rolvram 3 월 전

Blackrock keeps accumulating
https://stockzoa.com/ticker/phat/ownership/blackrock/#google_vignette

Monksdream

Monksdream 5 월 전

PHAT new 52=high

MiamiGent

MiamiGent 7 월 전

PHAT Nice! Account increased 11%! Was stacked.

MiamiGent

MiamiGent 7 월 전

PHAT 28.5% Revenue beat!

MiamiGent

MiamiGent 7 월 전

FALCON1

FALCON1 7 월 전

https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation

MiamiGent

MiamiGent 7 월 전

HC Wainwright & Co. Reiterates Buy on Phathom Pharmaceuticals, Maintains $28 Price Target
BENZINGA

Jul-19-2024 6:41 a.m. ET

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (PHAT) with a Buy and maintains $28 price target.

MiamiGent

MiamiGent 7 월 전

PHAT I'm hanging in!

MiamiGent

MiamiGent 7 월 전

BRIEF-Phathom Pharmaceuticals Announces FDA Approval Of Voquezna® (Vonoprazan) Tablets For The Relief Of Heartburn Associated With Non-Erosive Gerd In Adults
REUTERS

Jul-18-2024 8:41 a.m. ET

July 18 (Reuters) - Phathom Pharmaceuticals Inc (PHAT) :

* PHATHOM PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF VOQUEZNA® (VONOPRAZAN) TABLETS FOR THE RELIEF OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GERD IN ADULTS

* PHATHOM PHARMACEUTICALS INC (PHAT): VOQUEZNA MET ITS PRIMARY ENDPOINT IN ITS PHASE 3 PIVOTAL TRIAL Source text for Eikon: Further company coverage:

MiamiGent

MiamiGent 7 월 전

MiamiGent

MiamiGent 7 월 전

PHAT In @ 12.60's

Monksdream

Monksdream 10 월 전

Monksdream

Monksdream 12 월 전

PHAT 10Q due March 7

Phathom Pharmaceuticals

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관